Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Thucydides Trap and gold

When an emerging power attempts to supplant a hegemonic power in international politics, major conflict often ensues. This is the definition of “The Thucydides Trap” as explained in a recent op-ed piece in The Japan Times . The Thucydides Trap (pron...
Richard (Rick) Mills | June 14, 2019 |

Bringing the World Closer With a Language App

Hello Pal is a social mobile messaging app that surpasses the language learning barrier and be communicating with anyone around the world within minutes. You start searching out people to learn a language, and talk in a language that you&CloseCurlyQuo...
BTV-Business Television | June 9, 2018 |

Investors Run From Stocks At Record Pace

BIGGEST WITHDRAWALS ON RECORD There is a lot of relevant information in the text below from a Wall Street Journal article dated December 8, 2019 : “Investors have pulled $135.5 billion from U.S. stock-focused mutual funds and exchange-traded funds so far this year, th...
Chris Ciovacco | December 10, 2019 |

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

Buzz on the Bullboards: Stocks to watch in volatile times.

This week, Canada’s main stock index, the TSX , hit another record high, supported by strong retail sales data and positive investor sentiment. However, the index quickly fell from grace following U.S. President-elect Donald Trump’s announ...
Jonathon Brown | November 28, 2024 |

Transportation stock breakout is a good omen for the economy

The transportation stocks often lead the economy in both directions. That makes sense since truckers and railroads get an early look at the beginning stage of economic reversals in both directions. They get to see changes in the shipments of raw materials to manufacturers, s...
Sy Harding | January 14, 2013 |

Fund Manager Reveals His Top Ten Precious Metals List

Streetwise Reports: Ralph, gold has been trading within a relatively narrow range around $1,300 over the last several months. What's your outlook for the metal? Ralph Aldis: Longer term, I do think we're going to see a higher gold price. As for the near-term factors...
Streetwise Reports | May 10, 2019 |

Is the Fed Gearing Up for a New Round of Quantitative Easing? Here Are the Possible Signs

“This is not QE. In no sense is this QE.” That was Jerome Powell in early October, answering a reporter’s question on whether the Federal Reserve’s intervention in the overnight U.S. repo market constituted anoth...
Frank Holmes | December 11, 2019 |

Where to Get Income in a Low-Yield World

So far in 2020, the yield on the 10-year Treasury has averaged an anemic 0.01 percent when adjusted for inflation. Since the end of January, it’s actually dipped below 0 percent, trading as low as negative 0.14 percent on January 31. What this means is...
Frank Holmes | February 18, 2020 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |
1 2 3 4 5 6 7 8 9